Insmed Inc [INSM] stock prices are up 0.26% to $177.88 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INSM shares have gain 6.80% over the last week, with a monthly amount drifted -14.90%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Rothschild & Co Redburn started tracking the stock with Buy rating on December 04, 2025, and set its price target to $263. Wells Fargo started tracking the stock assigning an Overweight rating and suggested a price target of $171 on October 20, 2025. William Blair initiated its recommendation with an Outperform. Morgan Stanley downgraded its rating to Equal-Weight for this stock on August 13, 2025, but kept the price target unchanged to $126. In a note dated May 13, 2025, Jefferies initiated a Buy rating and provided a target price of $105 on this stock.
The stock price of Insmed Inc [INSM] has been fluctuating between $60.40 and $212.75 over the past year. Currently, Wall Street analysts expect the stock to reach $217.07 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $177.88 at the most recent close of the market. An investor can expect a potential return of 22.03% based on the average INSM price forecast.
Analyzing the INSM fundamentals
The Insmed Inc [NASDAQ:INSM] reported sales of 447.02M for trailing twelve months, representing a surge of 52.36%. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at -2.72%, Pretax Profit Margin comes in at -2.64%, and Net Profit Margin reading is -2.65%. To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -1.84 and Total Capital is -0.63. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 176.55 points at the first support level, and at 175.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 179.32, and for the 2nd resistance point, it is at 180.77.
Ratios To Look Out For
It’s worth pointing out that Insmed Inc [NASDAQ:INSM]’s Current Ratio is 4.63. Further, the Quick Ratio stands at 4.34, while the Cash Ratio is 0.8. Considering the valuation of this stock, the price to sales ratio is 84.87, the price to book ratio is 39.99.
Transactions by insiders
Recent insider trading involved Lewis William, Chair and CEO, that happened on Dec 18 ’25 when 10699.0 shares were sold. Officer, William Lewis completed a deal on Dec 18 ’25 to buy 10699.0 shares. Meanwhile, Director SHAROKY MELVIN MD sold 20000.0 shares on Dec 05 ’25.
